PubMed ID: 38848110 Author(s): Arzbecker M, Kopplin LJ. Manifestations and Management of Inflammatory Eye Disease in Patients with Inflammatory Bowel Disease. Ocul Immunol Inflamm. 2024 Dec;32(10):2348-2353. doi: 10.1080/09273948.2024.2362881. Epub 2024 Jun 7. PMID 38848110 Journal: …
All Posts
Targeted NAD+ repletion via biomimetic nanoparticle enables simultaneous management of intimal hyperplasia and accelerated re-endothelialization: A proof-of-concept study toward next-generation of endothelium-protective, anti-restenotic therapy.
PubMed ID: 39461367 Author(s): Yin L, Tong Y, Xie R, Zhang Z, Islam ZH, Zhang K, Burger J, Hoyt N, Kent EW, Marcum WA, Johnston C, Kanchetty R, Tetz Z, Stanisic S, Huang Y, Guo …
Biomarkers.
PubMed ID: 39785830 Author(s): Planalp BM, Hulle CAV, Bendlin BB, Blennow K, Quijano-Rubio C, Engelman CD, Kollmorgen G, Ma Y, Okonkwo OC, Carlsson CM, Johnson SC, Zetterberg H, Merten N. Biomarkers. Alzheimers Dement. 2024 Dec;20 …
Clinical Manifestations.
PubMed ID: 39750602 Author(s): Merten N, Pinto AA, Paulsen AJ, Chappell RJ, Chen Y, Engelman CD, Hancock LM, Johnson SC, Schubert CR. Clinical Manifestations. Alzheimers Dement. 2024 Dec;20 Suppl 3:e086737. doi: 10.1002/alz.086737. PMID 39750602 Journal: …
Longitudinal Assessment of Age-Related Macular Degeneration Using Ultrawidefield Imaging: The Optos Peripheral Retina Follow-up Study.
PubMed ID: 39617059 Author(s): Froines CP, Pak JW, Agron E, Chew EY, Peto T, Blodi BA, Domalpally A. Longitudinal Assessment of AMD using Ultrawide Field Imaging – The Optos PEripheral RetinA (OPERA) Follow-up Study. Ophthalmology. …
Effects of 0.024% latanoprostene bunod on intraocular pressure and pupil diameter in normal cats and cats with congenital glaucoma.
PubMed ID: 39609901 Author(s): Yang VY, Eaton JS, Kiland JA, Koch KE, Oikawa K, Hetzel SJ, McLellan GJ. Effects of 0.024% latanoprostene bunod on intraocular pressure and pupil diameter in normal cats and cats with …
Macular Edema Ranibizumab versus Intravitreal Anti-inflammatory Therapy Trial: 24-Week Outcomes of Uveitic Macular Edema Re-treatment.
PubMed ID: 39612949 Author(s): Multicenter Uveitis Steroid Treatment Trial (MUST) Research Group, Writing Committee; Gonzales J, Acharya NR, Sugar EA, Burke AE, Vitale AT, Gupta V, Dunn JP, Lightman SL, Thorne JE, Kim RY, Yeh …
Here’s What Ophthalmologists are Buying for Their Kids This Holiday Season
December is Safe Toys and Celebrations Month. Find out what ophthalmologists are buying for their kids this holiday season,
Taking Steps to Restore Vision: Launching a Stem Cell Clinical Trial for Retinitis Pigmentosa
The FDA has approved a groundbreaking stem cell clinical trial for retinitis pigmentosa. The trial is the next step in the work spearheaded by world-renowned vision researcher David Gamm, MD, PhD.